{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:31:14Z","timestamp":1776745874865,"version":"3.51.2"},"reference-count":12,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,21]]},"DOI":"10.1182\/blood.2023021094","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T15:34:21Z","timestamp":1695310461000},"page":"1029-1031","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["CARs put age in the rearview mirror"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-6480","authenticated-orcid":false,"given":"Ciara L.","family":"Freeman","sequence":"first","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Locke","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"12","key":"2023092115341459200_bib1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.2023020197","article-title":"Real-world experience of CAR T-cell therapy in older patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"142","author":"Chihara","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2023092115341459200_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/bjh.17206","article-title":"Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study","volume":"193","author":"Abu Sabaa","year":"2021","journal-title":"Br J Haematol"},{"issue":"7","key":"2023092115341459200_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10343","key":"2023092115341459200_bib4","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/S0140-6736(22)00662-6","article-title":"Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase\u00a03 trial","volume":"399","author":"Kamdar","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"2023092115341459200_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jtct.2023.04.003","article-title":"Overcoming barriers to referral for chimeric antigen receptor T cell therapy in patients with relapsed\/refractory diffuse large B cell lymphoma","volume":"29","author":"Hoffmann","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"2023092115341459200_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000492272","article-title":"Decision making criteria in oncology","volume":"98","author":"Glatzer","year":"2020","journal-title":"Oncology (Williston Park)"},{"issue":"27","key":"2023092115341459200_bib7","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1200\/JCO.19.02104","article-title":"Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium","volume":"38","author":"Nastoupil","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"2023092115341459200_bib8","doi-asserted-by":"crossref","first-page":"581.e1","DOI":"10.1016\/j.jtct.2022.05.026","article-title":"Real-world evidence of axicabtagene ciloleucel for the treatment of large B cell lymphoma in the United States","volume":"28","author":"Jacobson","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"2023092115341459200_bib9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41591-022-01969-y","article-title":"A\u00a0real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma","volume":"28","author":"Bachy","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"2023092115341459200_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3324\/haematol.2021.278288","article-title":"Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study","volume":"107","author":"Ram","year":"2022","journal-title":"Haematologica"},{"issue":"6","key":"2023092115341459200_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11912-022-01240-0","article-title":"Rehabilitation needs for patients undergoing CAR T-cell therapy","volume":"24","author":"Obaisi","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"2023092115341459200_bib12","unstructured":"SEER\u2217Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute. 2023. Accessed 8 June 2023. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/12\/1029\/2077526\/blood_bld-2023-021094-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/12\/1029\/2077526\/blood_bld-2023-021094-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T15:34:29Z","timestamp":1695310469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/12\/1029\/497860\/CARs-put-age-in-the-rearview-mirror"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021094","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}